Michael G Fehlings Selected Research

Neurologic Manifestations (Neurological Manifestations)

3/2022	Steroids in the Management of Preoperative Neurological Deficits in Metastatic Spine Disease: Results From the EPOSO Study.
12/2019	Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment for metastatic epidural spinal cord compression.
11/2019	The changes in systemic monocytes in humans undergoing surgical decompression for degenerative cervical myelopathy may influence clinical neurological recovery.
5/2019	Management of Acute Traumatic Central Cord Syndrome: A Narrative Review.
9/2017	Do Formal Laminectomy and Timing of Decompression for Patients With Sacral Fracture and Neurologic Deficit Affect Outcome?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael G Fehlings Research Topics

Disease

135	Spinal Cord Injuries (Spinal Cord Injury) 03/2024 - 01/2002
40	Spinal Cord Diseases 03/2024 - 05/2011
29	Wounds and Injuries (Trauma) 03/2024 - 01/2002
21	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2009
21	Neoplasms (Cancer) 01/2023 - 04/2004
18	Pain (Aches) 12/2023 - 06/2008
18	Gliosis 01/2023 - 02/2002
16	Inflammation (Inflammations) 01/2022 - 06/2004
12	Congenital Abnormalities (Deformity) 03/2024 - 02/2005
11	Contusions 01/2021 - 05/2012
10	Spinal Injuries (Spinal Injury) 01/2023 - 05/2011
9	Ischemia 12/2022 - 06/2004
9	Spinal Cord Compression 03/2022 - 11/2013
9	Neuroinflammatory Diseases 01/2021 - 05/2010
8	Radiculopathy (Radiculopathy, Cervical) 01/2023 - 09/2007
8	Intervertebral Disc Degeneration 05/2021 - 08/2009
8	Hemorrhage 08/2018 - 09/2011
7	Central Cord Syndrome 03/2024 - 10/2010
6	Stroke (Strokes) 11/2023 - 04/2004
6	Frailty 03/2023 - 10/2018
6	Neuralgia (Stump Neuralgia) 01/2023 - 04/2008
6	Aneurysm (Aneurysms) 01/2017 - 02/2002
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 09/2012
5	Hypoxia (Hypoxemia) 12/2022 - 06/2009
5	Neurologic Manifestations (Neurological Manifestations) 03/2022 - 09/2017
5	Disease Progression 02/2022 - 06/2012
5	Spondylolisthesis 01/2022 - 12/2008
5	Cicatrix (Scar) 01/2022 - 06/2012
5	Pneumonia (Pneumonitis) 01/2022 - 09/2012
5	Hypothermia 01/2017 - 12/2003
4	Demyelinating Diseases (Demyelinating Disease) 05/2024 - 02/2002
4	Hypertension (High Blood Pressure) 03/2024 - 05/2014
4	Infections 01/2023 - 12/2003
4	Reperfusion Injury 11/2019 - 12/2015
4	Paralysis (Palsy) 09/2019 - 10/2013
4	Pulmonary Embolism 09/2017 - 01/2008
4	Hyperalgesia 06/2017 - 04/2008
3	Deglutition Disorders (Dysphagia) 09/2022 - 11/2005
3	Kyphosis 01/2021 - 08/2009
3	Central Nervous System Diseases (CNS Diseases) 01/2021 - 11/2011
3	Guillain-Barre Syndrome 07/2019 - 09/2012
3	Pathologic Constriction (Stenosis) 12/2018 - 03/2012
3	Quadriplegia (Spastic Quadriplegia) 04/2017 - 07/2005
3	Arachnoiditis 07/2012 - 04/2008
2	Brain Injuries (Brain Injury) 01/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

20	Riluzole FDA LinkGeneric 01/2023 - 01/2002
12	CytokinesIBA 10/2020 - 05/2010
9	Methylprednisolone FDA LinkGeneric 01/2023 - 11/2013
8	Neuroprotective AgentsIBA 01/2021 - 10/2002
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 09/2013
7	Minocycline (Cyclops)FDA LinkGeneric 01/2017 - 07/2003
6	salicylhydroxamic acid (SHAM)IBA 01/2023 - 09/2007
6	Proteins (Proteins, Gene)FDA Link 11/2012 - 02/2002
5	Dichlorodiphenyldichloroethane (DDD)IBA 05/2021 - 01/2011
5	Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric 01/2021 - 01/2008
5	Clostridium botulinum exoenzyme C3IBA 01/2017 - 01/2007
5	Glutamic Acid (Glutamate)FDA Link 05/2014 - 06/2004
4	AnticoagulantsIBA 11/2023 - 05/2014
4	SteroidsIBA 03/2022 - 10/2015
4	Immunoglobulin G (IgG)IBA 01/2021 - 05/2010
4	Chondroitin Sulfate ProteoglycansIBA 01/2017 - 02/2010
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2016 - 12/2003
4	SodiumIBA 05/2014 - 01/2002
4	Sodium Channels (Sodium Channel)IBA 05/2014 - 01/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 02/2010
3	Complement System Proteins (Complement)IBA 01/2023 - 03/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 12/2002
3	ChemokinesIBA 07/2018 - 12/2011
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2017 - 02/2010
3	AntibodiesIBA 01/2017 - 05/2006
3	Oxygen (Dioxygen)IBA 01/2016 - 05/2006
3	Free RadicalsIBA 07/2015 - 06/2004
3	fas Receptor (CD95 Antigen)IBA 05/2012 - 05/2006
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2010 - 07/2005
2	IronIBA 05/2024 - 01/2022
2	mesoglycanIBA 04/2024 - 12/2023
2	AutoantibodiesIBA 01/2023 - 09/2021
2	Sodium Glutamate (Accent)IBA 01/2023 - 08/2010
2	Biocompatible Materials (Biomaterials)IBA 12/2022 - 12/2020

Therapy/Procedure

57	Therapeutics 07/2023 - 07/2005
42	Surgical Decompression 03/2024 - 01/2007
41	Decompression 01/2022 - 12/2003
21	Transplantation 01/2023 - 03/2006
18	Radiotherapy 06/2023 - 03/2011
17	Surgical Instruments (Clip) 01/2021 - 02/2002
10	Laminectomy 05/2021 - 02/2005
9	Length of Stay 01/2023 - 08/2011
8	Diskectomy (Discectomy) 01/2023 - 08/2009
6	Osteotomy 03/2024 - 01/2017
6	Cell Transplantation 12/2022 - 08/2011
6	Operative Surgical Procedures 01/2022 - 02/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
4	Ligation 01/2017 - 09/2011
3	Critical Care (Surgical Intensive Care) 03/2024 - 07/2015
3	Reoperation 01/2021 - 07/2017
3	Spinal Fusion (Spondylosyndesis) 01/2020 - 11/2012
3	Foraminotomy 01/2019 - 04/2009
3	Laminoplasty 01/2017 - 10/2013
3	Conservative Treatment 04/2016 - 10/2013
3	Arthroplasty 05/2014 - 08/2009